Investigators demonstrated that targeting Caenorhabditis elegans Von Hippel–Lindau (VHL)-1 proteins could markedly suppress neural pathologies, loss of long-lasting behavioral memory, and population mortality induced by transgenic human APOE4.
[Proceedings of The National Academy of Sciences of The United States of America]